Real-world evidence of off-label use of commercially automated insulin delivery systems compared to multiple daily insulin injections in pregnancies complicated by type 1 diabetes.
Quirós C, Herrera MT, Amigó J, Wagner A, Beato-Vibora PI, Azriel S, Climent E, Soldevila B, Barquiel B, Colomo N, Durán-Martínez M, Corcoy R, Codina M, Díaz-Soto G, Márquez-Pardo R, Martínez-Brocca MA, Rebollo Román Á, López Gallardo G, Cuesta M, García Fernández J, Goya MM, Vega Guedes B, Mendoza-Mathison LC, Perea V.
Quirós C, et al. Among authors: corcoy r.
Diabetes Technol Ther. 2024 Feb 28. doi: 10.1089/dia.2023.0594. Online ahead of print.
Diabetes Technol Ther. 2024.
PMID: 38417014